Ferrero Group maintains its growth trajectory with a 4.6% increase in turnover to EUR 19.3 billion. Strategy of innovation, portfolio expansion and acquisitions drove continued success in 2024/25. Platform for future growth further supported by increased capital investment of close to EUR 1.1 billion in 2024/25 and the acquisition of WK Kellogg Co. which closed in […]
Category Archives: Pr Newswire
SHENZHEN, China, Feb. 6, 2026 /PRNewswire/ — Following its recognition as a CES 2026 Innovation Award Honoree, the iGarden M1 Pro Max has officially launched globally today, establishing a new technical standard as the World’s First Bionic Dual-Vision pool cleaner. This flagship device moves beyond the blind randomization of legacy robots by constructing a biomimetic “Eye, […]
ALISO VIEJO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) — SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma”), a late-stage biopharmaceutical company, today announced the pricing of its initial public offering of 9,375,000 shares of its common stock at a public offering price of $16.00 per share. The aggregate gross proceeds from the offering, before deducting underwriting […]
ROCKVILLE, Md. and SUZHOU, China, Feb. 05, 2026 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that its novel next-generation Bruton’s tyrosine kinase (BTK)-targeted protein degrader, […]
Regional Growth Following Raleigh–Durham Brand Unification CHARLOTTE, NC, Feb. 05, 2026 (GLOBE NEWSWIRE) — His Choice Health today announced the upcoming opening of its newest clinic in Charlotte, targeted late February 2026, bringing its highly regarded, patient-centered model of men’s health care closer to families across the region. His Choice Health Vasectomies Available In Charlotte […]
52% Amtagvi Response Rate with Two or Fewer Prior Lines of Therapy 73% Overall Disease Control Rate SAN CARLOS, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced data […]
NASHVILLE, Tenn., Feb. 05, 2026 (GLOBE NEWSWIRE) — Renaissance Recovery, a District Behavioral Health Group (DBH) company, announced today the opening of its newest expansion in Nashville, Tennessee. As an award-winning, growing provider of addiction recovery and mental health treatment services, Renaissance Recovery is thrilled to expand access to evidence-backed, compassionate treatment for individuals seeking […]
HONG KONG, Feb. 6, 2026 /PRNewswire/ — Poised to Fill the Global Market Gap, the Serum-Free Iterative Rabies Vaccine Approaches a Critical Milestone in Commercialization. AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on February 5 that its wholly-owned subsidiary AIM Rongyu’s world’s first independently developed serum-free iterative rabies vaccine has successfully passed the […]
Love looks like care. This Valentine’s Day, VARON invites families to show love in a way that helps loved ones breathe easier—at home and on the go. NEW YORK, Feb. 6, 2026 /PRNewswire/ — VARON, a trusted provider of respiratory care solutions, today announced its Valentine’s Day Sale, a limited-time event designed to celebrate love through […]
MANILA, Philippines, Feb. 5, 2026 /PRNewswire/ — Valentine’s Day is traditionally associated with flowers and chocolates, but health experts encourage Filipinos to also prioritize well-being for themselves and their loved ones. Respiratory health is increasingly important as more people manage chronic conditions, recover from illness, or maintain active lifestyles amid environmental challenges. VARON Philippines marks the […]


